A DNA-based vaccine shows promise against avian flu

Oct 01, 2008

(PhysOrg.com) -- Though it has fallen from the headlines, a global pandemic caused by bird flu still has the United States’ Centers for Disease Control and Prevention on high alert. Yet, to date, the only vaccines that have proven even semi-effective are produced in chicken eggs, take five to six months to prepare and act against a single variant of the H5N1 virus, which mutates incredibly quickly. Now, new research by scientists in New York and Taiwan has led to a vaccine with the potential to stop most strains of H5N1 flu viruses in their tracks.

David D. Ho, Rockefeller’s Irene Diamond Professor and scientific director of the Aaron Diamond AIDS Research Center, together with his colleagues at Taiwan’s Academia Sinica, has built a vaccine that stimulates immunity to a broad range of H5N1 viruses in mice by using DNA rather than dead virus particles grown in eggs. Such a vaccine, which consists of plasmid DNA that’s been genetically modified to elicit specific immune responses, is much easier to rapidly modify and produce — critical advantages when racing to prevent an epidemic.

Ho and his collaborators first had to address virus specificity: Because H5N1 viruses are incredibly diverse, and mutate fast, the researchers created a consensus sequence that incorporated all of the conserved parts of the gene encoding the virus’s outer protein. Then they had to figure out how to deliver it.

This is where DNA vaccines often fail. They aren’t very good at making sure the DNA gets where it needs to go. To solve this problem, Ho and his colleagues turned to electroporation, a technique that is just beginning to gain traction in the vaccine world and that, according to preliminary studies, helps increase uptake of the vaccine. By combining their consensus-sequence vaccine with a small electric stimulus, the researchers found that their mouse subjects responded with an incredibly broad immune reaction.

“The immune responses directed to our DNA vaccine seem to be very broad,” Ho says. “It could be that the vaccine in its current form could protect against most of the H5N1 viruses out there.” And even if it can’t, he notes, if a different strain of H5N1 begins to circulate, it should only take a few days to obtain its genetic sequence and adapt the existing vaccine to fight it.

A version of the consensus vaccine is already being produced, Ho says, so that it can move into human clinical trials as quickly as possible. And a separate electroporation study is under way at The Rockefeller University Hospital, this one examining the effectiveness of electroporation combined with a DNA vaccine against HIV.

Citation: Proceedings of the National Academy of Sciences 105(36): 13538–13543 (September 9, 2008)

Provided by Rockefeller University

Explore further: Life-prolonging protein could inhibit ageing diseases

Related Stories

NIAID DNA vaccine for H5N1 avian influenza enters human trial

Jan 03, 2007

The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical ...

Researchers develop mRNA based flu vaccine

Nov 26, 2012

(Phys.org)—A joint research effort by the Friedrich-Loeffler-Institute and pharmaceutical company CureVac, both based in Germany, has resulted in the creation of a new type of flu vaccine. The vaccine, as the team describes ...

Scientists advance universal flu vaccine

Jul 15, 2010

A universal influenza vaccine - so-called because it could potentially provide protection from all flu strains for decades - may become a reality because of research led by scientists from the National Institute of Allergy ...

Flu shot might also offer some protection against H5N1

Feb 13, 2007

The yearly influenza vaccine that health officials urge people to get each fall might also offer certain individuals some cross protection against the H5N1 virus, commonly known as bird flu, according to investigators at ...

Recommended for you

Life-prolonging protein could inhibit ageing diseases

May 29, 2015

Researchers have found a molecule that plays a key link between dietary restriction and longevity in mammals. This discovery may lead to the development of new therapies to inhibit age-related diseases.

How sleep helps us learn and memorize

May 28, 2015

Sleep is important for long lasting memories, particularly during this exam season. Research publishing in PLOS Computational Biology suggests that sleeping triggers the synapses in our brain to both streng ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.